Publikation
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
Wissenschaftlicher Artikel/Review - 27.03.2019
Lingor Paul, Koch Jan C, Ludolph Albert, Frontini Roberto, Blankenstein Christiane, Bidner Helen, Kuzma-Kozakiewicz Magdalena, Benatar Michael, Günther René, Neuwirth Christoph, Leha Andreas, Hilgers Reinhard, Friede Tim, Camu William, Weber Markus, ROCK-ALS Investigators
Lingor, Paul
3
0
Weber, Markus
Klinik-/Instituts-/Zentrumsleiter/inMuskelzentrum | ALS Clinic · Dept. III
101
23
Camu, William
4
0
Friede, Tim
1
0
Hilgers, Reinhard
4
0
Leha, Andreas
2
0
Neuwirth, Christoph
Leitende(r) Arzt/ÄrztinMuskelzentrum | ALS Clinic · Dept. III
55
18
Günther, René
3
0
Benatar, Michael
4
0
Kuzma-Kozakiewicz, Magdalena
2
0
Bidner, Helen
1
0
Blankenstein, Christiane
1
0
Frontini, Roberto
1
0
Ludolph, Albert
6
0
Koch, Jan C
2
0
ROCK-ALS Investigators,
1
0